Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4.

Paalme V, Rump A, Mädo K, Teras M, Truumees B, Aitai H, Ratas K, Bourge M, Chiang CS, Ghalali A, Tordjmann T, Teras J, Boudinot P, Kanellopoulos JM, Rüütel Boudinot S.

Front Immunol. 2019 Sep 6;10:2074. doi: 10.3389/fimmu.2019.02074. eCollection 2019.

2.

The Water Extract of Juniperus communis L. Induces Cell Death and Sensitizes Cancer Cells to Cytostatic Drugs through p53 and PI3K/Akt Pathways.

Raasmaja A, Stenius U, Ghalali A.

Int J Mol Sci. 2019 Apr 26;20(9). pii: E2054. doi: 10.3390/ijms20092054.

3.

Developing a novel FRET assay, targeting the binding between Antizyme-AZIN.

Ghalali A, Rice JM, Kusztos A, Jernigan FE, Zetter BR, Rogers MS.

Sci Rep. 2019 Mar 15;9(1):4632. doi: 10.1038/s41598-019-40929-4.

4.

Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.

Bertacchini J, Mediani L, Beretti F, Guida M, Ghalali A, Brugnoli F, Bertagnolo V, Petricoin E, Poti F, Arioli J, Anselmi L, Bari A, McCubrey J, Martelli AM, Cocco L, Capitani S, Marmiroli S.

J Cell Physiol. 2019 Jul;234(7):11188-11199. doi: 10.1002/jcp.27768. Epub 2018 Nov 22.

PMID:
30565691
5.

CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.

Nilchian A, Johansson J, Ghalali A, Asanin ST, Santiago A, Rosencrantz O, Sollerbrant K, Vincent CT, Sund M, Stenius U, Fuxe J.

Cancer Res. 2019 Jan 1;79(1):47-60. doi: 10.1158/0008-5472.CAN-18-1742. Epub 2018 Nov 1.

PMID:
30385615
6.

Toluene diisocyanate exposure and autotaxin-lysophosphatidic acid signalling.

Broström JM, Ghalali A, Zheng H, Högberg J, Stenius U, Littorin M, Tinnerberg H, Broberg K.

Toxicol Appl Pharmacol. 2018 Sep 15;355:43-51. doi: 10.1016/j.taap.2018.06.019. Epub 2018 Jun 22.

PMID:
29940203
7.

Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors.

Ghalali A, Martin-Renedo J, Högberg J, Stenius U.

Mol Cancer Res. 2017 Jun;15(6):714-722. doi: 10.1158/1541-7786.MCR-16-0373. Epub 2017 Feb 16.

8.
9.

Toluene diisocyanate: Induction of the autotaxin-lysophosphatidic acid axis and its association with airways symptoms.

Broström JM, Ye ZW, Axmon A, Littorin M, Tinnerberg H, Lindh CH, Zheng H, Ghalali A, Stenius U, Jönsson BA, Högberg J.

Toxicol Appl Pharmacol. 2015 Sep 15;287(3):222-31. doi: 10.1016/j.taap.2015.06.006. Epub 2015 Jun 11.

PMID:
26072274
10.
11.

Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.

Ghalali A, Wiklund F, Zheng H, Stenius U, Högberg J.

Carcinogenesis. 2014 Jul;35(7):1547-55. doi: 10.1093/carcin/bgu019. Epub 2014 Jan 22.

PMID:
24451147
12.

Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.

Karim H, Ghalali A, Lafolie P, Vitols S, Fotoohi AK.

Biochem Biophys Res Commun. 2013 Jul 26;437(2):280-6. doi: 10.1016/j.bbrc.2013.06.067. Epub 2013 Jun 27.

PMID:
23811272
13.

Silencing p110β prevents rapid depletion of nuclear pAkt.

Ye ZW, Ghalali A, Högberg J, Stenius U.

Biochem Biophys Res Commun. 2011 Dec 2;415(4):613-8. doi: 10.1016/j.bbrc.2011.10.120. Epub 2011 Nov 3.

PMID:
22074824
14.

Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases.

Mistafa O, Ghalali A, Kadekar S, Högberg J, Stenius U.

J Biol Chem. 2010 Sep 3;285(36):27900-10. doi: 10.1074/jbc.M110.117093. Epub 2010 Jul 6.

Supplemental Content

Loading ...
Support Center